Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is a leader in molecular pathology, specializing in the development of cell- and tissue-based diagnostic tests for personalized medicine. Founded in 2006 and headquartered in Newark, California, ACD has field offices in Italy, China, and Japan.
Product Portfolio:
- RNAscope™ Technology: ACD's proprietary RNAscope™ is an advanced in situ hybridization (ISH) platform that enables the detection and quantification of RNA within intact cells, offering single-molecule sensitivity and high specificity.
- BaseScope™ and miRNAscope™ Assays: These assays complement the RNAscope™ technology by allowing the detection of short RNA sequences and splice variants, expanding the scope of RNA analysis in research and diagnostics.
